🔎 Trials Near Me

홈 › 비소세포폐암 › 워싱턴 D.C.

워싱턴 D.C.의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 38개가 워싱턴 D.C. 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴 D.C.의 도시

공식 연구 텍스트(영어)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT04267848

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Local Institution - 0183, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07680764

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06472245

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05498428

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • MedStar Georgetown University Hospital, Washington D.C.
  • Washington DC VA Medical Center, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Georgetown University, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07154290

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Washington DC Veterans Affairs Medical Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • MedStar Georgetown University Hospital, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
  • MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06712316

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  • George Washington University Cancer Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07195695

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Georgetown University Lombardi Cancer Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT05786924

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Local Institution - 007-5476, Washington D.C.
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT04613596

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

  • MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT04302025

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  • Washington Hospital Center ( Site 0037), Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06422143

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  • MedStar Georgetown University Hospital, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07288177

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06586515

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

  • Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07111520

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06706076

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06449313

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

  • Georgetown University, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT05098132

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 30. 업데이트됨 · NCT06162221

Gilteritinib for the Treatment of ALK NSCLC

  • Georgetown University, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 26. 업데이트됨 · NCT06225427

Study of XB010 in Subjects With Solid Tumors

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06545331

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  • Georgetown University Medical Cener (GUMC), Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT07154706

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Research Site, Washington D.C.
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 5. 14. 업데이트됨 · NCT06417814

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06031688

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06810544

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
  • Medstar Washington Hospital Center, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT04499053

Repositioning Immunotherapy in VetArans With Lung Cancer

  • VA Central Office, Washington, DC, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 2. 업데이트됨 · NCT06275360

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The George Washington University Cancer Center (site 212), Washington D.C.
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT03556228

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 7. 2. 업데이트됨 · NCT06669117

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.